Pennington Partners & Co’s Eli Lilly LLY Stock Holding History

Pennington Partners & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$817K	Sell	681 -53	-7%	-$54.2K	0.26%	49
2026 Q1	$675K	Buy	734 +479	+188%	+$486K	0.23%	53
2025 Q4	$274K	Buy	+255	New	+$244K	0.11%	79
2025 Q2	–	Sell	-315	Closed	-$260K	–	85
2025 Q1	$260K	Sell	315 -265	-46%	-$221K	0.15%	64
2024 Q4	$448K	Buy	+580	New	+$480K	0.22%	50

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pennington Partners & Co's LLY Position: Q2 2026 in Review

Pennington Partners & Co reduced its Eli Lilly (LLY) stake by 7.2% in Q2 2026, selling an estimated $54.2K and leaving 681 shares worth $817K. The position accounts for 0.26% of the portfolio, ranked #49.

Pennington Partners & Co first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Pennington Partners & Co held 681 shares of Eli Lilly worth $817K as of Q2 2026.
Pennington Partners & Co sold 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
Eli Lilly made up 0.26% of Pennington Partners & Co's portfolio in Q2 2026, its #49 holding.
Pennington Partners & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pennington Partners & Co's 13F filing for Q2 2026, filed 14 Aug 2026.